Charles Bonnet Syndrome as the First Sign of Alzheimer’s Disease
Hort J.1, Propper L.2, Hořínek D.3, Škoda D.1, Bojar M.1
1Neurologická klinika 2. LF UK, Praha 2Dětská psychiatrická klinika 2. LF UK, Praha 3Anatomický ústav 1. LF UK, Praha |
|
Summary:
The authors have presented a case-report of a 75-year-old woman receiving psychopharmacological
treatment due to five-years’ history of visual pseudohallucinations.
Four years after the onset, the patient was examined, and then followed
by neurologists due to deterioration of her cognitive functions. She was extensively
examined – neuropsychology, MRI volumometry, CSF assessment (including
biomarkers total-tau protein, phosphorylated-tau protein, beta-amyloid), SPECT,
DaTSCAN and laboratory screening. In accordance with clinical picture the
results led to the diagnosis of Alzheimer’s disease, which was initially manifested
by Charles Bonnet syndrome. Differential diagnosis of dementias, particularly
those with Lewy bodies, and a possible association of cognitive deficit with mental
health issues (hallucinations) are discussed.
Key words:
Charles Bonnet syndrome, cognitive deficit, Alzheimer’s disease
|